thinkstockAnother presidential debate is on deck. With election season set to take off into full overdrive in the weeks and months ahead, 24/7 Wall St. wanted to take a statistical view of each candidate…
Oracle reported mixed fiscal first-quarter financial results after the markets closed on Wednesday.
ThinkstockSeptember 16, 2015: Here are four stocks trading with heavy volume among 46 equities making new 52-week lows today. United States Steel Corp. (NYSE: X) posted a new 52-week low on Wednesday. Shares dropped…
thinkstockSeptember 16, 2015: Markets opened higher again on Wednesday apparently anticipating no action by the Fed to raise interest money. The consumer price index dropped which also worked against a rate hike tomorrow. Crude…
This is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy.
The twice-delayed auction for the assets of bankrupt Patriot Coal has attracted another potential bidder, according to the company’s attorney,
According to Fitch Ratings, biosimilars are beginning to take share from their reference biologics. This is seen in the debut of the first biosimilar drug in the United States.
The latest data from the U.S. Census Bureau on poverty, health insurance and income shows an alarming number of people aged 20 to 35 (millennials) are still going without health insurance.
If Moody’s Investors Service is right, the world’s largest oil companies will experience a contraction of 20% in their cash flows in 2015.
Brokerage firm Oppenheimer came away from recent meetings with Home Depot senior executives even more confident in its near and longer term positive stance on shares.
Glencore has placed a total of more than a billion new ordinary shares in the London-traded company with existing and new institutional shareholders, as well as certain company officials and employees.
The expected price range for the SynCardia Systems IPO is $10 to $12 for 2.5 million shares.
The NAHB/Wells Fargo housing market index has remained above 50 since last July, following a sharp drop in the first half of 2014.
Amgen and Xencor have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.
The U.S. Energy Information Administration says U.S. commercial crude inventories decreased by 2.1 million barrels last week.